XYMOGEN LipiChol
Reason Product was labeled as a medical food as opposed to a dietary supplement.
LipiChol 540 recall
Recalled by Atlantic Pro Nutrients, Inc. dba XYMOGEN · Orlando, FL, United States
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Product was labeled as a medical food as opposed to a dietary supplement.
A label that does not match the product can hide an ingredient someone must avoid, or show a wrong use-by date. All labeling errors recalls.
What was recalled
LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida
Quantity: 25,852 bottles (All Brands)
Lot codes, dates and UPCs
A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.
UPC # N3 53731-001-06 9 Lot # 50001784 exp. 09/2014, lot # 50001783 exp. 09/2014, lot # 50002588 exp 11/2015, and lot # 50002587 exp. 11/2015
Where it was sold
Nationwide.
Alaska
FDA's distribution note: Nationwide and Alaska Canada and China
Low risk, but check. Class III means the product is unlikely to make anyone ill but breaks an FDA rule, often a labeling one. If your package matches, the store will normally refund it. FDA lists this recall as terminated: the company has finished removing the product, so it should no longer be on shelves - but it can still be in a freezer or pantry.
- Recalling firm
- Atlantic Pro Nutrients, Inc. dba XYMOGEN
- Initiated by
- Voluntary: Firm initiated
- Recall initiated
- Aug 16, 2013
- In FDA report of
- Jan 8, 2014
- Terminated
- May 2, 2014
- FDA recall number
- F-0816-2014 · event 66135
- Official record
- FDA enforcement report search
Also recalled with it (1 more product)
FDA files each product of one recall action separately; these share the same FDA event.
Other recalls by Atlantic Pro Nutrients, Inc. dba XYMOGEN
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen…
Reason Undeclared Soy and Milk on the label.